{"id":95871,"date":"2024-02-01T08:45:04","date_gmt":"2024-02-01T07:45:04","guid":{"rendered":"https:\/\/www.nordicturk.com\/tr-int\/?p=95871"},"modified":"2024-02-01T08:45:04","modified_gmt":"2024-02-01T07:45:04","slug":"ozempic-ve-wegovy-para-basti-novo-nordiskten-rekor-kar","status":"publish","type":"post","link":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/is-dunyasi\/ozempic-ve-wegovy-para-basti-novo-nordiskten-rekor-kar\/95871\/","title":{"rendered":"Ozempic ve Wegovy para bast\u0131: Novo Nordisk&#8217;ten rekor k\u00e2r"},"content":{"rendered":"<p>Danimarka k\u00f6kenli sa\u011fl\u0131k \u015firketi Novo Nordisk, 2023 y\u0131l\u0131nda 102.6  milyar kron (450.6 milyar lira) faaliyet k\u00e2r\u0131 elde etti. <\/p>\n<p>Novo Nordisk, 2023 y\u0131l\u0131na dair faaliyet raporunu a\u00e7\u0131klad\u0131. <\/p>\n<p>\u015eirket taraf\u0131ndan a\u00e7\u0131klanan faaliyet raporuna g\u00f6re, Novo Nordisk, 2023 y\u0131l\u0131nda 232.2 milyar kron (1 trilyon 20 milyar lira) net sat\u0131\u015f yapt\u0131. <\/p>\n<p>\u015eirketin 2023\u2019te faaliyet kar\u0131 ise 102.6 milyar (450.6 milyar lira) oldu. <\/p>\n<p>Ge\u00e7en y\u0131l\u0131 rekor k\u00e2r ile kapatan Novo Nordisk, tarihinde ilk defa 100 milyar kron (439 milyar lira) faaliyet k\u00e2r baraj\u0131n\u0131 a\u015ft\u0131. <\/p>\n<p>\u015eirketin 2023 y\u0131l\u0131 i\u00e7in net k\u00e2r\u0131 ise 83.7 milyar krona (368 milyar lira) ula\u015ft\u0131. <\/p>\n<p>\u015eirket 2022 y\u0131l\u0131 i\u00e7in 75 milyar kron (329 milyar lira) faaliyet k\u00e2r\u0131 a\u00e7\u0131klam\u0131\u015ft\u0131. \u015eirket, 2022 y\u0131l\u0131 i\u00e7inde 55.5 milyar kron (244 milyar lira) net k\u00e2r elde etmi\u015fti. <\/p>\n<p>Novo Nordisk, 2023 y\u0131l\u0131nda, 2022 y\u0131l\u0131na oranla net k\u00e2r\u0131n\u0131 y\u00fczde 51 art\u0131rd\u0131. <\/p>\n<p>\u015eirketin 2023 y\u0131l\u0131nda ula\u015ft\u0131\u011f\u0131 tarihi ba\u015far\u0131s\u0131n\u0131n ard\u0131nda, obizete ilac\u0131 Wegovy ile tip 2 diyabet ilac\u0131 Ozempic taraf\u0131ndan ula\u015f\u0131lan sat\u0131\u015f ba\u015far\u0131s\u0131 g\u00f6steriliyor.  <\/p>\n<p>\u015eirketin \u00e7ok tart\u0131\u015f\u0131lan obezite ilac\u0131 Wegovy\u2019nin sat\u0131\u015f\u0131 2023 y\u0131l\u0131nda 5 kat artt\u0131. \u015eirket bu sat\u0131\u015ftan d\u00fcnya genelinde 31 milyar kron (136 milyar lira) ciro elde etti. <\/p>\n<p>Tip 2 diyabet hastalar\u0131na y\u00f6nelik olan Ozempic ise 2023 y\u0131l\u0131nda d\u00fcnya genelinde 95 milyar kron (417 milyar lira) ciroya ula\u015ft\u0131. <\/p>\n<figure id=\"attachment_95876\" aria-describedby=\"caption-attachment-95876\" style=\"width: 1260px\" class=\"wp-caption alignleft\"><img decoding=\"async\" src=\"https:\/\/www.nordicturk.com\/tr-int\/wp-content\/uploads\/2024\/01\/novo-nordisk-kalundborg-insulin-uretim.jpg\" alt=\"\" width=\"1260\" height=\"840\" class=\"size-full wp-image-95876\" srcset=\"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-content\/uploads\/2024\/01\/novo-nordisk-kalundborg-insulin-uretim.jpg 1260w, https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-content\/uploads\/2024\/01\/novo-nordisk-kalundborg-insulin-uretim-300x200.jpg 300w, https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-content\/uploads\/2024\/01\/novo-nordisk-kalundborg-insulin-uretim-1024x683.jpg 1024w, https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-content\/uploads\/2024\/01\/novo-nordisk-kalundborg-insulin-uretim-768x512.jpg 768w, https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-content\/uploads\/2024\/01\/novo-nordisk-kalundborg-insulin-uretim-750x500.jpg 750w, https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-content\/uploads\/2024\/01\/novo-nordisk-kalundborg-insulin-uretim-1140x760.jpg 1140w\" sizes=\"(max-width: 1260px) 100vw, 1260px\" \/><figcaption id=\"caption-attachment-95876\" class=\"wp-caption-text\">Novo Nordisk&#8217;in Danimarka&#8217;n\u0131n Kalundborg \u015fehrinde bulunan fabrikas\u0131nda ins\u00fclin \u00fcretimi.<\/figcaption><\/figure>\n<h3>Novo Nordisk<\/h3>\n<p>K\u00fcresel sa\u011fl\u0131k \u015firketi Novo Nordisk 1923 y\u0131l\u0131nda Danimarka\u2019da kuruldu.<\/p>\n<p>D\u00fcnya genelinde 80 \u00fclkede faaliyet g\u00f6steren \u015firketin \u00fcr\u00fcnleri 170 \u00fclkede hastalar\u0131n eri\u015fimine sunulmakta.<\/p>\n<p>Diyabetin yan\u0131 s\u0131ra, obezite ila\u00e7lar\u0131yla sa\u011fl\u0131k sekt\u00f6r\u00fcnde d\u00fcnyan\u0131n \u00f6nde gelen \u015firketleri aras\u0131nda yer alan Novo Nordisk\u2019in k\u00fcresel \u00e7apta 64 bin 319 \u00e7al\u0131\u015fan\u0131 bulunuyor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Danimarkal\u0131 sa\u011fl\u0131k \u015firketi Novo Nordisk, 2023 y\u0131l\u0131nda 102.6 milyar kron (450.6 milyar lira) faaliyet k\u00e2r\u0131 ile tarihinde ilk kez 100 milyar kron (439 milyar lira) baraj\u0131n\u0131 ge\u00e7ti.<\/p>\n","protected":false},"author":12,"featured_media":95875,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"2","single_blog_custom":"","parallax":"1","fullscreen":"0","layout":"right-sidebar","sidebar":"right","second_sidebar":"right","sticky_sidebar":"0","share_position":"hide","share_float_style":"share-normal","show_share_counter":"1","show_view_counter":"1","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"custom","post_date_format_custom":"j F Y l - H:i","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"0","show_popup_post":"0","number_popup_post":"1","show_author_box":"0","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"no-crop","single_post_gallery_size":"crop-715"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"footnotes":""},"categories":[8],"tags":[79,288,293,292],"coauthors":[98],"class_list":["post-95871","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-is-dunyasi","tag-danimarka","tag-novo-nordisk","tag-ozempic","tag-wegovy"],"_links":{"self":[{"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/posts\/95871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/comments?post=95871"}],"version-history":[{"count":0,"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/posts\/95871\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/media\/95875"}],"wp:attachment":[{"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/media?parent=95871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/categories?post=95871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/tags?post=95871"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.nordicturk.com\/arsiv\/20122025\/wp-json\/wp\/v2\/coauthors?post=95871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}